At the Joint ENC-ISMAR Conference 2025, Bruker (BRKR) Corporation announced the launch of a Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration. This novel Fourier 80 ‘Multi-Talent’ system represents a major advancement in permanent magnet-based FT-NMR technology, as its unique, next-generation capabilities meet the evolving needs of academic researchers and industry scientists with dramatically enhanced versatility in benchtop FT-NMR multinuclear analysis.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker price target lowered to $50 from $75 at Citi
- Bruker’s Strong Market Position and Growth Potential Drive Buy Rating
- Bruker Corporation: A Strategic Buy Amid Market Concerns and Growth Opportunities
- Bruker’s Promising Market Position and Growth Prospects Justify Buy Rating
- Bruker Maintains Strong Buy Rating Amidst Innovations in Spatial Biology and Strategic Financial Management